These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9816747

  • 1. [AIDS triple therapy. The gap between viral load and side effects].
    Gürtler L.
    Fortschr Med; 1998 Sep 30; 116(27):4-5. PubMed ID: 9816747
    [No Abstract] [Full Text] [Related]

  • 2. Nonnucleoside reverse transcriptase inhibitors.
    Murphy RL.
    AIDS Clin Care; 1997 Oct 30; 9(10):75-7, 79. PubMed ID: 11364757
    [Abstract] [Full Text] [Related]

  • 3. The end of AIDS?
    Leland J.
    Newsweek; 1996 Dec 02; 128(23):64-8, 71, 73. PubMed ID: 10162943
    [No Abstract] [Full Text] [Related]

  • 4. Undetectable HIV levels after triple therapy with indinavir.
    AIDS Patient Care STDS; 1997 Jun 02; 11(3):193-4. PubMed ID: 11361795
    [No Abstract] [Full Text] [Related]

  • 5. Lipodystrophy--nukes vs. protease inhibitors.
    TreatmentUpdate; 2001 Jul 02; 13(3):5-6. PubMed ID: 11569989
    [No Abstract] [Full Text] [Related]

  • 6. Drug interactions, toxicities, dosages: trials and tribulations and cocktails.
    Crit Path AIDS Proj; 1998 Jul 02; (No 33):9-17. PubMed ID: 11366377
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of drug cocktail combinations for their immunological value in preventing/remitting opportunistic infections.
    Konlee M.
    Posit Health News; 1998 Jul 02; (No 16):2-4. PubMed ID: 11365016
    [Abstract] [Full Text] [Related]

  • 8. To AIDS and back with Norvir, D4T, 3TC and nutritional therapies. An interview with Michael Golk.
    Golk M.
    Posit Health News; 1998 Jul 02; (No 16):5-7. PubMed ID: 11365018
    [Abstract] [Full Text] [Related]

  • 9. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
    Reiser M, Salzberger B, Stiepel A, Hoetelmans R, Diehl V, Fätkenheuer G.
    Eur J Med Res; 1999 Feb 25; 4(2):54-8. PubMed ID: 10066640
    [Abstract] [Full Text] [Related]

  • 10. [Non-nucleoside reverse transcriptase inhibitor as a fully viable alternative. Strong therapy start without protease inhibitor].
    MMW Fortschr Med; 2000 Mar 13; 142 Suppl 1():30-3. PubMed ID: 10863307
    [No Abstract] [Full Text] [Related]

  • 11. Rescue me.
    Simmons P.
    Res Initiat Treat Action; 1998 Aug 13; 4(5):10. PubMed ID: 11365705
    [Abstract] [Full Text] [Related]

  • 12. Initiation of antiretroviral therapy: implications of recent findings.
    Saag MS.
    Top HIV Med; 2004 Aug 13; 12(3):83-8. PubMed ID: 15310939
    [Abstract] [Full Text] [Related]

  • 13. Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1.
    Clevenbergh P, Kirstetter M, Liotier JY, Dupon M, Philibert P, Jacomet C, Cua E, Montagne N, Schmit JC, Dellamonica P.
    Antivir Ther; 2002 Dec 13; 7(4):305-8. PubMed ID: 12553486
    [Abstract] [Full Text] [Related]

  • 14. Ritonavir and saquinavir combination: 12-week data at ICAAC.
    James JS.
    AIDS Treat News; 1996 Oct 04; (No 256):3. PubMed ID: 11363880
    [Abstract] [Full Text] [Related]

  • 15. Improvement in CD4+ cell counts despite persistently detectable HIV load.
    Levitz SM.
    N Engl J Med; 1998 Apr 09; 338(15):1074-5. PubMed ID: 9537882
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of HIV infections and AIDS with protease inhibitor and two nucleoside analogs].
    Jensen-Fangel S, Larsen L, Thomsen HF, Nielsen LP, Black FT, Obel N.
    Ugeskr Laeger; 1999 Mar 22; 161(12):1751-4. PubMed ID: 10210974
    [Abstract] [Full Text] [Related]

  • 17. Another take on when to start and how to succeed.
    Friedland GH.
    AIDS Clin Care; 2001 Sep 22; 13(9):82. PubMed ID: 11547600
    [No Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
    Michelet C, Bellissant E, Ruffault A, Arvieux C, Delfraissy JF, Raffi F, Bazin C, Renard I, Sébille V, Chauvin JP, Dohin E, Cartier F.
    Clin Pharmacol Ther; 1999 Jun 22; 65(6):661-71. PubMed ID: 10391672
    [Abstract] [Full Text] [Related]

  • 19. AIDS researchers emphasize new drug combinations.
    Fox JL.
    Nat Biotechnol; 1997 Mar 22; 15(3):215. PubMed ID: 9062914
    [No Abstract] [Full Text] [Related]

  • 20. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
    Negredo E, Paredes R, Bonjoch A, Tuldrà A, Fumaz CR, Gel S, Garcés B, Johnston S, Arnó A, Balagué M, Jou A, Tural C, Sirera G, Romeu J, Cruz L, Francia E, Domingo P, Arrizabalaga J, Ruiz I, Arribas JR, Ruiz L, Clotet B.
    Antivir Ther; 1999 Mar 22; 4 Suppl 3():23-8. PubMed ID: 16021868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.